The relationship between local cerebral glu cose utilization (LCGU) and local CBF (LCBF) was ex amined during the action of ,(-hydroxybutyrate (GHB) (900 mg/kg i. v.) in conscious rats. GHB induced dis crepant effects on blood flow and metabolism. LCGU was markedly depressed in all structures examined, whereas LCBF was differently affected in that no related changes were observed. Global glucose utilization was markedly depressed ( -51%), whereas global blood flow Abbreviations used: GHB, -y-hydroxybutyrate; LCBF, local CB F; LCGU , local cerebral glucose utilization.
The close correlation between metabolism and blood flow in the brain has recently been assessed by direct measurement of local cerebral glucose uti lization (LCGU) and local CBF (LCBF) in a variety of cerebral structures (Sokoloff, 1978; Kuschinsky et al., 1981; McCulloch et al., 1982a; Nakai et al., 1983) . The mechanism that mediates this relation ship is not yet understood. Numerous studies have been carried out to elucidate the mechanism of the hyperemia that accompanies functional activation of the brain. Under these conditions, hyperemia ap pears to be triggered by the increased release of metabolically linked vasodilator substances. A number of candidates exist for such a local meta bolic control, e.g., H+, K +, adenosine, etc. [for references see Kuschinsky and Wahl (1978) and Kuschinsky (1982) ], because their extravascular concentrations increase during functional activation to levels that induce vasodilation of pial arteries. Whereas such local metabolic factors seem to be mediators of hyperemia induced by acute functional activation, the question still remains as to whether these factors are also responsible for the heteroge neity of LCBF that under normal conditions is closely correlated with local metabolism (Sokoloff, 1978; Kuschinsky et al., 1981; McCulloch et al., 1982a; Nakai et al., 1983) .
To investigate this question, the influence of marked metabolic depression on the relationship between local cerebral metabolism and blood flow was examined. ,),-Hydroxybutyrate (GHB) was chosen as a metabolic depressant. It is a naturally occurring substance in mammalian brain (Bessman and Fishbein, 1963; Roth, 1970; Roth and Giarman, 1970) . Its pharmacological effects have been re viewed recently (Snead, 1977) . As shown earlier for ,),-butyrolactone (Wolfson et al., 1977) , GHB in high doses apparently reduces global cerebral energy metabolism by �50% if one extrapolates from local values.
METHODS
The experiments were performed on normal adult male Sprague-Dawley rats weighing 330-430 g. LCGU and LCBF were measured by the methods described by So koloff et al. (1977) and Sakurada et al. (1978) , respec tively. The animals were anesthetized with halothane and N20, and polyethylene catheters were inserted into a femoral artery and vein. The rats were then placed in loose-fitting plaster casts and immobilized from the ab domen to the hind legs; the head, forelegs, and thorax were unrestrained. At least 3 h was allowed for complete recovery from the effects of anesthesia.
For the measurement of LCGU, 125 fLCilkg of 2-deoxy D-[1-14C]glucose (specific activity 50-56 mCilmmol; New England Nuclear Corp., Boston, MA, U.S.A) was in jected as a pulse via the femoral venous catheter within 20 s, and timed arterial blood samples of �80 fLl each were collected through the femoral arterial catheter at 15, 30, and 45 s and 1, 2,3,5, 7. 5, 10, 15,25,35 , and 45 min. The blood samples were immediately centrifuged, and the plasma was separated and stored on ice until assayed for [14C]deoxyglucose and glucose concentrations as previ ously described (Sokoloff et aI., 1977) . Immediately after the final arterial blood sample was collected, the animal was decapitated, and the brain was rapidly removed and frozen in 2-methylbutane chilled to -40 to -50°C with dry ice.
For the measurement of LCBF, 50 fLCi of 4-iodo-N methyl-[14C]antipyrine (specific activity 54 mCi/mmol; Amersham/Searle Corp., Arlington Heights, IL, U.S.A.) in the 1.5 ml of saline was continuously infused at a pro gressively increasing rate via the femoral venous catheter for a period of I min. The progressively increasing infu sion rate was a modification of the method described ear lier (Sakurada et aI., 1978) . It was chosen to minimize equilibration of rapidly perfused tissues with arterial blood during the period of measurement. During the 1min infusion period, 16-18 timed blood samples were col lected in drops from the free-flowing arterial catheter di rectly onto filter paper discs (1.3 cm in diameter) that had previously been placed in small plastic beakers and weighed. The samples were weighed and counted in the same manner as described earlier (Sakurada et aI., 1978) . After the I-min infusion and sampling period, the animal was decapitated, and the brain was removed as quickly as possible and frozen, as described for the deoxyglucose experiments.
In both the deoxyglucose and iodoantipyrine experi ments, the frozen brains were coated with chilled embed ding medium (Lipshaw Manufacturing Co., Detroit, Ml, U.S.A.), stored at -70°C in plastic bags, sectioned into 20-fLm sections at -22°C in a cryostat, and autoradio graphed along with calibrated [14C]methylmethacrylate standards as described previously (Sokoloff et aI., 1977) . Local tissue concentrations of 14C were determined from the autoradiographs by densitometric analysis with a den sitometer (model 520-A; Photovolt, New York, NY, U.S.A.) equipped with a 0. (1978) ]. LCGU was measured in a control group of five normal rats and in a group of five rats that were treated with 900 mg/kg of GHB (Na salt; Sigma Chemical Co., St. Louis, MO, U.S.A.). LCBF was determined in a control group of seven rats and in four treated with GHB. This dose of GHB is equimolar to the dose of 600 mg/kg of -y-butyro lactone used by Wolfson et al. (1977) . The full dose of GHB was dissolved in 1.5 ml of saline; 1 ml of this so lution was injected intravenously 45 min and the re maining 0.5 milS min before administration of either the deoxyglucose or the iodoantipyrine.
Statistical evaluation of the effect of GHB on either LCGU or LCBF was performed by Student's t test for ungrouped data. The relationship between LCGU and LCBF was quantified by linear regression analysis. Be cause of the limitations of this kind of analysis, an addi tional, more rigorous statistical approach was used by applying the analysis described by McCulloch et al. (1982a) . This test employs logged data, includes animal effects, and allows detection of heterogeneities of the re lationship between LCGU and LCBF.
RESULTS
Ta ble 1 shows the acid-base status and the arterial blood pressure of the rats before and after GHB administration. The acid-base status was not signif icantly changed by GHB, except for an increase in arterial Pco2 (p < 0. 01). The acid-base status mea sured during the control phase before the injection of GHB was in close agreement with that of the untreated control rats in the deoxyglucose and io doantipyrine studies. Therefore, the data for the acid-base status of the control groups are not in cluded in Ta ble 1.
The effects of GHB on LCGU of the various ce rebral structures are shown in Fig. 1 and for se lected specific structures in Ta ble 2. Glucose utili zation was significantly reduced (p < 0. 01) in all structures. The decrease in glucose utilization pro duced by GHB varied from -67% (visual cortex) Values are means ± SD. a Significantly different from control (p < 0. 01). to -25% (inferior colliculus). There was a corre lation (r = 0.82) between the values of LCGU be fore and after GRB administration ( Fig. O . When average glucose utilization was determined for the brain as a whole (Goochee et aI. , 1980) , the weighted average value showed a reduction of 51% below the level of the control group.
In contrast to the marked reduction in global glu- Table  2 ). The maximal changes in LCBF were found in the cerebellar hemisphere (+92%) and the medial geniculate body (-44%). Although the changes in local blood flow included both increases and de creases, there was still a significant correlation (r = 0.81) between the values of LCBF before and after GRB administration. The marked discrepancy between the effects on global blood flow and global metabolism, mani fested by a generalized decrease in glucose utiliza tion and the varying changes in blood flow, is not completely reflected in the local values. This is demonstrated in Fig. 3 in which the relationships between LCGU and LCBF have been plotted for both the control and the GRB-treated groups. The values for LCBF and LCGU for each brain struc- 44 ± 5 23 ± 11a 44 ± 9 45 ± 11 37 ± 6 21 ± 5a 46 ± 5 37 ± 7b 33 ± 2 21 ± 80 43 ± 5 38 ± 5 42 ± 5 24 ± 7" 42 ± 7 41 ± 9 28 ± 4 14 ± 5a 39 ± 11 37 ± \3 pointed to a heterogeneity of the relationship be tween LCGU and LCBF during control condi tions that was comparable with that reported by McCulloch et al. (l982a) . During GHB administra tion, the heterogeneity of the relationship between LCGU and LCBF was increased. The extreme values were obtained for the cerebellar hemisphere, ventral thalamus, visual cortex, and parietal cortex (LCBF/LCGU ratio between 6.2 and 5 mli/-Lmol) and for white matter, substantia nigra, and hypo-thalamus (LCBF/LCGU ratio between 1.65 and 1.97 mll/-lmol).
DISCUSSION
The results of the present studies suggest dis crepant effects of GHB on global blood flow and global metabolism in the brain. The marked reduc tion in global cerebral glucose utilization is not re flected in a proportionate change in global blood flow. This dissociation in the global values is not completely reflected in the correlation between local glucose utilization and local blood flow, which is mainly preserved, although the heterogeneity of the relationship is increased.
The observed decrease in glucose utilization is in accordance with earlier observations in this labo ratory on the effects of l'-butyrolactone (Wolfson et aI. , 1977; Crosby et aI. , 1983) . Although burst suppression activity in the EEG is expected with the doses used in the present and the former studies (Winters and Spooner, 1965; Snead et aI., 1976; Wolfson et aI. , 1977) , it was not accompanied by increased local glucose utilization, which occurs with seizure activity (Collins, 1976; Collins et aI. , 1976) . The observed depression in glucose utiliza tion must represent a decrease in brain energy me tabolism, because the utilization of fuels other than glucose of the required magnitude can be excluded. The replacement of glucose by as much as 50% could be effected only by a large increase in ketone bodies in plasma, but the plasma concentration of the major ketone body, D-[3-hydroxybutyrate, was not significantly changed [e. g. , 0.171 ± 0.083 mM (x ± SD) during control conditions and 0.191 ± 0.077 mM after GHB administration] (R. Bunger and W. Kuschinsky, unpublished observations) . The decreased glucose utilization cannot be ex plained by secondary effects of GHB, such as hy pothermia or metabolic acidosis. Hypothermia has been found after administration of GHB (Laborit, 1964) , but it was controlled and avoided in the present studies by continuous recording of the body temperature and heating of the animal as necessary to maintain body temperature. Metabolic acidosis can also reduce brain metabolism (Kuschinsky et aI. , 1981) . Metabolic acidosis is produced by l'-bu tyrolactone, but not by the sodium salt of GHB (MacMillan, 1978; Artru et aI. , 1980) , which was used in the present studies and did not induce major changes in blood base status (Table 1) , except for a slight increase in arterial Peo2• The increased Peo2 probably enhanced the depressant effect of GHB on glucose utilization inasmuch as the breathing of 5% CO2 has been found to reduce glucose utiliza tion of gray matter structures by 32% and of white matter structures by 37% (Des Rosiers et aI., 1978) . Vol. 5, No. I, 1985 The present findings on the effects of GHB on CBF in the awake rat are not in accord with those reported in the literature for the anesthetized dog (Artru et aI. , 1980; Baumann et aI. , 1982) and cat (Bendikov et aI. , 1979) . They are, however, in agreement with data obtained in the conscious rat (Johansson and Hardebo, 1982) . The discrepancy between the results obtained in the cat and dog and those obtained in the present studies in the rat may be due to the anesthesia used in the former but may also reflect methodological problems. For example, calculation of CBF from recordings with electro magnetic flowmeters at the carotid artery of the cat (Bendikov et aI. , 1979) is not justified because of the existence of extra-to intracranial anastomoses. The relatively high blood flows found in the present study during GHB administration also do not ap pear to be attributable to increased blood pressure. The range of cerebral autoregulation in the rat is �70-180 mm Hg (Gross et aI., 1981) , and the blood pressures measured in the present study were well within that range (Table 1) . With a higher dose of GHB, a significant increase in blood pressure was reported to occur in the rat, which led to a moderate change of the blood-brain barrier at an unchanged CBF (Johansson and Hardebo, 1982) . Therefore, a moderate increase in the permeability of the blood brain barrier cannot be completely excluded in the present experiments although it is unlikely because of the lower dose of GHB used.
Resetting of the relationship between LCGU and LCBF has been observed previously in other con ditions. An increased slope of the relationship be tween LCGU and LCBF has been observed in met abolic acidosis (Kuschinsky et aI. , 1981) and during norepinephrine infusion (Kuschinsky et aI., 1983) , and a decreased slope has been reported to occur after indomethacin administration (McCulloch et ai. , 1982b) . Change in the slope is not always found, however. Apomorphine (McCulloch et ai. , 1982a) and muscimol (Kelly and McCulloch, 1983) as well as stimulation of the dorsal reticular formation (Ia decola et ai., 1983) do not affect the slope. In the present study, the easiest explanation for the ob served resetting is offered by the increase in arterial Peo2 during GHB experiments. Ta king a flow change of 5%/mm Hg (Gross et ai. , 1981) and the increase in arterial Peo2 of 8 mm Hg, global flow should increase by 40%. This could grossly com pensate the flow decrease expected because of the decreased metabolism.
Explanations for a resetting under some condi tions and not under others are still lacking. They will require more understanding of the mechanisms responsible for the normal adjustment of local blood flow to local metabolic demands. Besides local met-abolic factors, the distribution of cerebral blood vessels may be of importance. This seems possible, since an inhomogeneous distribution of capillaries in brain is well known. Variations of capillary density by a factor of 4 (Zeman and Innes, 1963) and 10 (Lierse and Horstmann, 1965) have been measured in normal brains, depending on the specific brain structure. The dependency of capillary density on functional needs was demonstrated by a 10-19% reduction of capillary density in structures of the visual system of the brain after blinding (Zeman and Innes, 1963) . However, a pure anatomical ap proach, as taken by measuring capillary density, may not solve the question quantitatively if the blood flow in each structure is determined by cap illary density. Under physiological conditions, the capillaries may not be all open at the same time (Bean et aI. , 1971; Leniger-Follert et aI. , 1975; Ozanne et aI. , 1975) . The present experiments are compatible with the following hypothesis: Whereas increased blood flow in a brain structure during functional activation (functional hyperemia) may be triggered by local chemical factors, this mechanism of vascular adjustment to metabolic demand may not be the one chiefly responsible for the inhomo geneity of blood flow found in the normal brain in correspondence with the inhomogeneity of local metabolism. Future experiments must show if cap illary density and/or other factors are causing the distribution of flow under these conditions.
